Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.43 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28108200 | 0.95 | ACP3 (0.46) | ACP3HSD17B10CYP1A2HPGDCYP2C19 | |
| SCHEMBL7028514 | 0.80 | KIF11 (0.45) | ACP3HSD17B10CYP1A2HPGDCYP2C19 | |
| SCHEMBL2187746 | 0.80 | HSD17B10 (0.43) | ACP3HSD17B10CYP1A2HPGDCYP2C19 | |
| SCHEMBL6242753 | 0.78 | CYP1A2 (0.42) | ACP3HSD17B10CYP1A2HPGDCYP2C19 | |
| SCHEMBL3003485 | 0.78 | CYP3A4 (0.42) | ACP3HSD17B10CYP1A2HPGDCYP2C19 | |
| SCHEMBL648242 | 0.78 | HSD17B10 (0.42) | ACP3HSD17B10CYP1A2HPGDCYP2C19 | |
| SCHEMBL2355481 | 0.78 | CYP1A2 (0.59) | ACP3HSD17B10CYP1A2HPGDCYP2C19 | |
| SCHEMBL5013862 | 0.78 | TSHR (0.42) | ACP3HSD17B10CYP1A2HPGDCYP2C19 | |
| SCHEMBL15212262 | 0.78 | HSD17B10 (0.42) | ACP3HSD17B10CYP1A2HPGDCYP2C19 | |
| SCHEMBL6241697 | 0.78 | CYP1A2 (0.42) | ACP3HSD17B10CYP1A2HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | JSI SILICONE CO. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20210188739-A1 | METHOD FOR PRODUCING ARENE COMPOUNDS AND ARENE COMPOUNDS PRODUCED BY THE SAME | JSI SILICONE CO. (KR) | 2021-06-24 | — | — | US | disclosed |
| CN-101218299-B | Fine particle-dispersed polyol composition, method for producing polymer polyol, and method for producing polyurethane resin | SANYO CHEMICAL IND LTD | 2012-06-20 | — | — | CN | disclosed |
| CN-101253249-B | Thermosetting solvent-free single-component substances and use thereof | DELO INDUSTRIEKLEBSTOFFE GMBH | 2012-06-06 | — | — | CN | disclosed |
| CN-102276973-A | Method for producing polymer polyol, and method for producing polyurethane resin | — | 2011-12-14 | — | — | CN | disclosed |
| CN-101802045-A | Polyurethane and polyurea, and method for producing the same | TOYOTA JIDOSHOKKI KK | 2010-08-11 | — | — | CN | disclosed |
| US-20080207864-A1 | Organosilanes, Process For Production of the Same, and Use Thereof | SHARP KABUSHIKI KAISHA (JP) | 2008-08-28 | — | — | US | disclosed |
| CN-101218299-A | Fine particle-dispersed polyol composition, method for producing polymer polyol, and method for producing polyurethane resin | SANYO CHEMICAL IND LTD (JP) | 2008-07-09 | — | — | CN | disclosed |
| US-6013656-A | PSYCHOLOGICAL DISORDERS; GASTROINTESTINAL DISORDERS; NERVOUSSYSTEM DISORDERS | WARNER-LAMBERT COMPANY (US) | 2000-01-11 | — | — | US | disclosed |
| US-5849760-A | 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors | INSTITUT DE RECHERCHE JOUVEINAL (FR) | 1998-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210188739-A1 | METHOD FOR PRODUCING ARENE COMPOUNDS AND ARENE COMPOUNDS PRODUCED BY THE SAME | PFAS, FRK, AGPAT2 | ACP3 399/4885HSD17B10 1306/4885CYP1A2 303/4885 |
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | PFAS, FRK, AGPAT2 | ACP3 399/4885HSD17B10 1306/4885CYP1A2 303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.